Bipolar Disorder
Conditions
Keywords
Real life setting, Bipolar Disorder, Registry based Data Base Audit
Brief summary
The aim of this study is to describe the treatment pattern and patient characteristics in real life setting in patients with Bipolar disorder treated with Seroquel XR and/or Seroquel IR in Sweden.
Detailed description
An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
Interventions
None listed
Sponsors
AstraZeneca
Study design
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with a diagnosis of BD.
Exclusion criteria
* Patients with a diagnosis of any schizophrenia spectrum disorder after the diagnosis of bipolar disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches, and add-on therapy, in patients with BD and on treatment with quetiapine XR and/or quetiapine IR before, at and after the index date. | 1st of January 2009 to 31st of December 2010. |
Secondary
| Measure | Time frame |
|---|---|
| Description of co-morbidity, demographics, sick leave, early retirement and socioeconomic factors in patients with BD and on treatment with quetiapine XR and/or quetiapine IR before and at the index date. | 1st of January 2009 to 31st of December 2010. |
| Description of the detailed clinical treatment in terms of duration of treatment, doses, drug switches, and add-on therapy, in patients with BD, including all drug treatment after the index date | 1st of January 2009 to 31st of December 2010. |
| Description of co-morbidity, demographics, sick leave, early retirement and socioeconomic factors in patients with BD, including all drug treatment before and at the index date | 1st of January 2009 to 31st of December 2010. |
Outcome results
None listed